The efficacy analysis of argon-helium cryoablation for localized prostate cancer
Objective To investigate the efficacy and safety of argon-helium cryoablation for localized prostate cancer.Methods The data of 21 patients with localized prostate cancer who under-went argon-helium cryoablation in our hospital from January 2014 to December 2019 were retrospective-ly analyze.Serum total prostate specific antigen(tPSA),international prostate symptom score(IP-SS),quality of life(QOL),MRI and whole body scan were evaluated,and biochemical recurrence and complications were recorded.Results At 3 months after surgery,the serum tPSA,IPSS and QOL scores of all patients were significantly lower than those before treatment,with statistical significance(all P<0.001).The serum tPSA level 6 months after surgery was lower than that 3 months after sur-gery,and the difference was statistically significant[(0.012±0.013)ng/mL vs.(0.096±0.174)ng/mL,P<0.05].Reexamination of prostate MRI one year after surgery indicated that prostate vol-ume decreased significantly,from pre-operation(44.85±19.66)mL to post-operation(19.90± 11.63)mL,with statistical significance(P<0.05).During follow-up,there were no deaths,no lo-cal progression or metastasis,two patients had long-term complications after surgery,and 1 patient had biochemical recurrence.Conclusions Cryoablation with argon-helium knife is an effective treatment for localized prostate cancer,and it can relieve urinary tract symptoms and improve quality of life.It is an optional treatment for localized prostate cancer.